Recomendaciones de manejo farmacológico en COVID-19
During the month of December last 2019, a series of cases of pneumonia were identified in Wuhan (China), which were caused by a new class of coronavirus. This new class of coronavirus has acquired different names, such as: 2019-nCoV named after the World Health Organization (WHO) and SARS-CoV-2, nam...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=7591559 |
| Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 4, Nº. 2, 2020, pags. 31-39 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| Summary: |
During the month of December last 2019, a series of cases of pneumonia were identified in Wuhan (China), which were caused by a new class of coronavirus. This new class of coronavirus has acquired different names, such as: 2019-nCoV named after the World Health Organization (WHO) and SARS-CoV-2, name given by the International Committee on Virus Taxonomy. The disease causing this virus has been named 2019-nCoV. As of May 4, 2020, the WHO had registered a total of 1,477,448 confirmed cases worldwide, a total of 86,342 deaths and the virus present in the 54 countries, areas and territories counted for epidemiological purposes. The current reality is that there is no specific pharmacological treatment for COVID-19 treatment whose efficacy and safety have been demonstrated. The fundamental purpose of this study is to capture the pharmacological treatment of COVID 19 that is managed internationally. The research design that was carried out is documentary or bibliographic. The most widely used drugs worldwide for the treatment of COVID 19 are: Hydroxy-chloroquine, Remdesivir, Lopinavir-Ritonavir, Interferon, Oseltamivir, Arbidol, Favipiravir and Vitamin C, among others. It is essential to contribute together as a society in the containment of this virus to save time in the investigation of drugs that guarantee effective treatment and vaccines that allow its prevention, and we hope that these literary reviews will contribute to continue treating in the best possible way to those infected with COVID-19. |
|---|